In Vitro Comparison of Lymphangiogenic Potential of Hypoxia Preconditioned Serum (HPS) and Platelet-Rich Plasma (PRP)

Strategies for therapeutic lymphangiogenesis are gradually directed toward the use of growth factor preparations. In particular, blood-derived growth factor products, including Hypoxia Preconditioned Serum (HPS) and Platelet-rich Plasma (PRP), are both clinically employed for accelerating tissue rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Jun, Cong, Xiaobin, Alageel, Sarah, Dornseifer, Ulf, Schilling, Arndt F., Hadjipanayi, Ektoras, Machens, Hans-Günther, Moog, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916704/
https://www.ncbi.nlm.nih.gov/pubmed/36768283
http://dx.doi.org/10.3390/ijms24031961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916704/
https://www.ncbi.nlm.nih.gov/pubmed/36768283
http://dx.doi.org/10.3390/ijms24031961

Ejemplares similares